• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

40例复发性结石形成者中尿结石形成抑制剂的研究

Inhibitors of urinary stone formation in 40 recurrent stone formers.

作者信息

François B, Cahen R, Pascal B

出版信息

Br J Urol. 1986 Oct;58(5):479-83. doi: 10.1111/j.1464-410x.1986.tb05450.x.

DOI:10.1111/j.1464-410x.1986.tb05450.x
PMID:3779347
Abstract

The excretion of four inhibitors of urinary stone formation (zinc, magnesium, citrates and glycosaminoglycans (GAG) was studied in 20 normal controls and 40 recurrent calcium stone formers who were placed on a fixed diet restricted in calcium, oxalates and purines. We were unable to show any abnormality in the excretion of Zn, Mg or GAG. In 11 patients, a low level of urinary citrate was a significant feature that was associated in most cases with a urinary pH value above 6. Citrate concentration (per litre) and output (per 24 h) were found to be lower than in the controls in 19 and 33% respectively of the determinations. The overall ratio of average urinary citrate concentration in patients and controls was 0.56, a figure in agreement with previous data.

摘要

在20名正常对照者和40名复发性钙结石形成者中研究了四种尿结石形成抑制剂(锌、镁、柠檬酸盐和糖胺聚糖(GAG))的排泄情况,这些患者采用限制钙、草酸盐和嘌呤的固定饮食。我们未能发现锌、镁或GAG排泄有任何异常。在11名患者中,尿柠檬酸盐水平低是一个显著特征,在大多数情况下与尿pH值高于6有关。分别有19%和33%的测定结果显示,患者的柠檬酸盐浓度(每升)和排泄量(每24小时)低于对照组。患者与对照组尿柠檬酸盐平均浓度的总体比值为0.56,这一数字与先前数据一致。

相似文献

1
Inhibitors of urinary stone formation in 40 recurrent stone formers.40例复发性结石形成者中尿结石形成抑制剂的研究
Br J Urol. 1986 Oct;58(5):479-83. doi: 10.1111/j.1464-410x.1986.tb05450.x.
2
Urinary glycosaminoglycan excretion in normal and stone-forming subjects: significant disturbance in recurrent stone formers.
Urol Int. 1989;44(3):157-9. doi: 10.1159/000281493.
3
Role of inhibitor deficiency in urolithiasis. I. Rationale of urinary magnesium, citrate, pyrophosphate and glycosaminoglycan determinations.抑制剂缺乏在尿路结石形成中的作用。I. 尿镁、柠檬酸盐、焦磷酸盐和糖胺聚糖测定的基本原理。
Eur Urol. 1991;19(3):240-3. doi: 10.1159/000473629.
4
Urinary excretion of citrate, glycosaminoglycans, magnesium and zinc in relation to age and sex in normal subjects and in patients who form calcium stones.正常人和形成钙结石患者的枸橼酸盐、糖胺聚糖、镁和锌的尿排泄与年龄及性别的关系。
Scand J Urol Nephrol. 1992;26(4):379-86. doi: 10.3109/00365599209181230.
5
Value of routine citrate analysis and calcium/citrate ratio in calcium urolithiasis.常规柠檬酸盐分析及钙/柠檬酸盐比值在钙结石症中的价值
Eur Urol. 1991;19(2):165-8. doi: 10.1159/000473606.
6
Changes in urinary composition of calcium oxalate stone formers.草酸钙结石形成者尿液成分的变化。
Biomed Pharmacother. 1986;40(3):108-10.
7
[Clinical studies on the recurrence of urolithiasis: (1). Influence of diet on urinary excretion of the stone forming constituents].尿路结石复发的临床研究:(1). 饮食对结石形成成分尿排泄的影响
Hinyokika Kiyo. 1987 Sep;33(9):1321-30.
8
Urinary citrate excretion in patients with urolithiasis and normal subjects.尿石症患者与正常受试者的尿枸橼酸盐排泄情况。
Eur Urol. 1989;16(5):382-5. doi: 10.1159/000471622.
9
[A study on the cause of urolithiasis of the upper urinary tract--clinical study of risk factors in the formation of stones in the upper urinary tract].[上尿路尿石症病因研究——上尿路结石形成危险因素的临床研究]
Hinyokika Kiyo. 1986 Mar;32(3):311-25.
10
Urinary citrate excretion in stone-formers and normal controls.
Br J Urol. 1976 Feb;48(1):7-11. doi: 10.1111/j.1464-410x.1976.tb02731.x.

引用本文的文献

1
Alcohol Intake and Prevalent Kidney Stone: The National Health and Nutrition Examination Survey 2007-2018.饮酒与常见肾结石:2007-2018 年全国健康与营养调查。
Nutrients. 2024 Sep 1;16(17):2928. doi: 10.3390/nu16172928.
2
The effects of drinking bicarbonate-rich mineral water in calcium oxalate stone formers: an open label prospective randomized controlled study in an Asian cohort.饮用富含碳酸氢盐的矿泉水对草酸钙结石患者的影响:一项针对亚洲队列的开放标签前瞻性随机对照研究。
Int Urol Nephrol. 2022 Sep;54(9):2133-2140. doi: 10.1007/s11255-022-03256-8. Epub 2022 Jul 4.
3
Protective effect of pentoxifylline on oxidative renal cell injury associated with renal crystal formation in a hyperoxaluric rat model.
己酮可可碱对高草酸尿症大鼠模型中与肾结晶形成相关的氧化肾细胞损伤的保护作用。
Urolithiasis. 2019 Oct;47(5):415-424. doi: 10.1007/s00240-018-1072-8. Epub 2018 Jul 6.
4
Kidney stone analysis techniques and the role of major and trace elements on their pathogenesis: a review.肾结石分析技术以及常量和微量元素在其发病机制中的作用:综述
Biophys Rev. 2014 Dec;6(3-4):291-310. doi: 10.1007/s12551-014-0144-4. Epub 2014 Jul 31.
5
Laser-induced breakdown spectroscopy is a reliable method for urinary stone analysis.激光诱导击穿光谱法是一种用于尿石分析的可靠方法。
Turk J Urol. 2016 Mar;42(1):21-6. doi: 10.5152/tud.2016.76402.
6
Antiurolithiatic Effects of Solanum xanthocarpum Fruit Extract on Ethylene-Glycol-Induced Nephrolithiasis in Rats.黄果茄果实提取物对乙二醇诱导的大鼠肾结石的抗结石作用
J Young Pharm. 2012 Jul;4(3):164-70. doi: 10.4103/0975-1483.100022.
7
Clinico-Biochemical indexing of calcium urolithiasis on the basis of urinary citrate to calcium ratio and inhibition of mineralisation of urinary stone forming minerals by human urine.基于尿柠檬酸与钙的比值以及人尿对尿结石形成矿物质矿化的抑制作用对钙尿石症进行临床生化指标测定
Indian J Clin Biochem. 2003 Jan;18(1):52-60. doi: 10.1007/BF02867665.
8
Serum, urinary and stone zinc, iron, magnesium and copper levels in idiopathic calcium oxalate stone patients.特发性草酸钙结石患者的血清、尿液及结石中的锌、铁、镁和铜水平
Int Urol Nephrol. 2007;39(2):351-6. doi: 10.1007/s11255-006-9050-4.